Inscriptio Us
Productus
Ceraphilic CCCXI-p
  • Ceraphilic CCCXI-pCeraphilic CCCXI-p

Ceraphilic CCCXI-p

Vos can requiem certo emere Ceraphilic CCCXI-p a factory et faciemus tibi optimis post-sale servitium et opportune partus. Synlotic est professional fabrica Ceramide seriem, volumus providere vobis Ceraphilic CCCXI-P, quod est auream Ratio pro Cemerterol: Cholesterol: ADIPATUS Acidum ad III: I: I.

Name: Ceramide NP, Hydrogenated Lysolecithin, Hydrogenated Lecithin, Lecithin, Cholesterol, Stearic Acidum

Specie lux flavo coloratum pulveris

Compositionem (%):

Name

Cas No.

% Range

Ceramide NP

72968-43-5

20.2

Hydrogenated lysolecithin

20

Hydrogenated Lecithin

92128-87-5

20.0 ~ 25.0

Lecithin

8002-43-5

20.0 ~ 25.0

Cholesterol

57-88-5

6.65

Acidum stearic

57-11-4

6.65


Beneficia:Anti-canus, reparare cutis obice, anti-inflammatory

Product Information:

Ceraphilic CCCXI-P est cutis meliorem agente. Neque aquam damnum cutis et amplio cutis textura ut lenis ad encapsulated Ceramide, cholesterol et pingue acidum. In compositione Ratio est III, I: I. Hoc est maxime idealis ratio ad compositionem Ceramide, cholesterol et pingue acida in cute. Hoc productum potest auxilium, ut custodiat et reparare cutis obice.


Formula Exempla:

Patet Ceramide 0,1% solution


Procedure:

I. calefactio tempus ad LXX ℃. Heating et dissolvere b ad LXX ℃.

II. Tardius posuit B in 450rpm.

III. Refrigerant cum movere ad L ℃

Suggestion Dosis:

0.5∽5.0% ad COLOR





Hot Tags: Ceraphilic CCCXI-P, manufacturer, synlotic biotech, cutis obice reparatione, anti-canus, anti-inflammatory, moisturizing, competitive Moring, reliable copia
Mitte Inquisitionem
Contactus info
Welcome to website! Nam quaestiones de nostris products et pricelist, quaeso relinquere vestri email ad nos et non erit in tactus intra XXIV horas.
E-mail
info2@synlotic.cn
Mobile
+86-15921518996
Oratio
No.377 Chengpu Road, Fengxian District, Shanghai, Sina.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept